ECCO-ESMO Patient advocacy symposium conclusions
3 Nov 2009
ECCO-ESMO Patient advocacy symposium conclusions
Costs of licensing clinical trials
Importance of exchanging scientific information
European Action Against Rare Cancers
Guidelines for safer handling of cytotoxics
Increasing prostate cancer awareness
Hyper-reactions to radiotherapy
Early detection of cancer
Targeted agents in the treatment of advanced NSCLC
NCRI presentation: Difficult decisions at the end of life
National Cancer Research Institute Conference, 4th-7th October 2009
Round table discussion on targeted therapies for metastatic breast cancer